ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01508026
Recruitment Status : Completed
First Posted : January 11, 2012
Last Update Posted : April 25, 2014
Sponsor:
Information provided by (Responsible Party):
Forest Laboratories

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : May 2013
  Certification/Extension First Submitted : March 28, 2014